Patent · US Active

Formulation for the use in the simultaneous treatment of coccidial infections and iron deficiencies

US12150952B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

Elanco Animal Health GmbH · DE

Inventors

Stefan Hofmann · Gauting, DE
Kirsten BÖRNGEN · Neunburg vorm Wald, DE
Maya Vinzing · Wuppertal, DE

Key dates

Filing date	May 29, 2019
Grant date	Nov 26, 2024
Priority date	—
Expiry date	Jul 2, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/44
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies containing a triazinone such as toltrazuril and a polynuclear iron(III) polysaccharide complex compound together with a specifically selected surfactant that has a hydrophilic-lipophilic-balance (HLB) value of ≥10.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.